Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine eye drops for nephropathic cystinosis (Cystadrops Phase III)
2009-012564-13Phase 3Completed
- Sponsor
- Recordati Rare Diseases
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cysteamine in nephropathic cystinosis and cystinosis (2 arms), sponsored by Recordati Rare Diseases. Primary endpoint: Corneal cystine crystal density. Started Jun 2013; status: completed.
02
Drugs
cysteamine
03
Conditions
nephropathic cystinosiscystinosis
Beyond the preview
Go deeper on 2009-012564-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012564-13.